Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - March, 2004
33 articles
- Tyco Ordered To Pay $135M In Patent Suit
- TKT Regains European Rights to Dynepo
- Court Rules Mylan Infringes J&J Duragesic Patent
- Judge Rules For Cytomedix In Patent Suit Over Platelet Releasates
- Benitec Sues Biotech Rivals Over RNAi Gene Silencing Technology
- Canada Committee Reviews Draft Of Landmark Generics Bill
- Mylan Sues Procter & Gamble and Watson Over "Authorized Generic"
- Endo Gets 180-Day Market Exclusivity For OxyContin
- Shire Buys Fosrenol Patent Rights for Up to $31 M
- Andrx Relinquishes 180-Day Exclusivity For Wellbutrin Generic, Ceding Ground To Eon
- Dr. Reddy's Files FDA ANDA For UCB Epilepsy Drug
- Glaxo Loses Patent For Seretide/Advair In U.K.
- Judge Rules For Abbott In Depakote Patent Suit Vs. Apotex Unit
- Bingham McCutchen Hires IP Attorneys In New York, Eyes Further Expansion
- Aventis Faces Threat Of Generic Competition For Lovenox
- E.U. Pharmaceutical Reform Package Comes Into Effect
- Pfizer Halts Ranbaxy's Diflucan Generic With Court Ruling
- Glaxo Eyes Court Ruling On Seritide Patent
- Pfizer To Sue Drug Maker Seeking FDA OK To Market Generic Detrol
- Aventis Files Additional Suits Over Allegra Patents
- ArthroCare Wins Permanent Injunction Against Smith & Nephew in Patent Infringement Lawsuit
- GSK Sues Bentley In Spain Over Paxil Generic
- EPO Board of Appeal OKs Agennix Patent Claims
- FDA OKs Generic Version Of Abbott's Tricor By Impax, Teva
- Diomed Expands Litigation Vs. Vascular Solutions With Patent Suit
- IMPAX Receives Final FDA Approval for Generic Version of Claritin-D 24-Hour
- Roche Diagnostics Sues Rivals Over Blood Glucose Monitors
- Australian Commission Proposes Amendments To Patent Law For Genetic Research
- Trade Group Blasts "Authorized Generic" Deals
- Judge Sets Deadline for Post-Trial Briefs In Zyprexa Case
- FDA To Disclose Dates Of Complete Generic Applications
- Biogen Idec Pays $20M To Settle Patent Suit With Corixa, GSK
- Brisk Start For U.S. Trademark Applications Under Madrid Protocol